MovDisordV3, France, Analysis, indexItem, Author.i, Michael P. Hill

Michael Orth < Michael P. Hill < Michael P. Mcdermott

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.

Ident.	Authors (with country if any)	Title
000383 (2006)	Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France]	Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors
000450 (2003)	Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimée [Belgique] ; Henrik Klitgaard [Belgique]	Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset

List of associated KwdEn.i

Nombre de documents	Descripteur
2	Animals
2	Callithrix
2	Dyskinesia
2	Levodopa
2	L‐dopa
2	Parkinson disease
2	dyskinesia
1	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)
1	Analysis of Variance
1	Animal
1	Animal model
1	Anticonvulsant
1	Anticonvulsants (pharmacology)
1	Anticonvulsants (therapeutic use)
1	Antiparkinson Agents (adverse effects)
1	Antiparkinson Agents (therapeutic use)
1	Antiparkinson agent
1	Behavior, Animal (drug effects)
1	Chemotherapy
1	Combined treatment
1	D2 Dopamine receptor
1	D2/D3 receptors
1	D3 Dopamine receptor
1	Disease Models, Animal
1	Dopamine Agents (adverse effects)
1	Dopamine Agents (metabolism)
1	Dopamine Antagonists (therapeutic use)
1	Dose-Response Relationship, Drug
1	Drug Administration Schedule
1	Drug Synergism
1	Drug Therapy, Combination
1	Female
1	Indoles (adverse effects)
1	Indoles (therapeutic use)
1	Levetiracetam
1	Levodopa (adverse effects)
1	Levodopa (therapeutic use)
1	MPTP
1	MPTP Poisoning (drug therapy)
1	MPTP Poisoning (physiopathology)
1	Male
1	Monkey
1	Motor Activity (drug effects)
1	Nervous system diseases
1	Oxazines (therapeutic use)
1	Parkinson's disease
1	Parkinsonian Disorders (chemically induced)
1	Parkinsonian Disorders (drug therapy)
1	Parkinsonian Disorders (metabolism)
1	Piperidines (therapeutic use)
1	Piracetam (analogs & derivatives)
1	Piracetam (pharmacology)
1	Piracetam (therapeutic use)
1	Receptors, Dopamine D2 (physiology)
1	Receptors, Dopamine D3 (physiology)
1	Ropinirole
1	Time Factors
1	neuronal firing patterns
1	ropinirole
1	synchronization

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Michael P. Hill"

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Michael P. Hill" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Michael P. Hill
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue) - Analysis (France) Index « Auteurs » - entrée « Michael P. Hill »
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue) - Analysis (France)Index « Auteurs » - entrée « Michael P. Hill »

List of bibliographic references

List of associated KwdEn.i

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Michael P. Hill »